Mckesson (MCK) Net Cash Flow Growth (1y) (2010 - 2026)
Mckesson (MCK) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.57 Bn | 97.41 Bn | 3.69 Bn | 136.24% |
| 2 | Cencora | 61.35 Bn | 58.53 Bn | 3.61 Bn | 617.55% |
| 3 | Cardinal Health | 54.15 Bn | 49.30 Bn | 2.56 Bn | 66.85% |
| 4 | Henry Schein | 10.05 Bn | 9.89 Bn | 1.10 Bn | -88.46% |
| 5 | Akso Health | 671.90 Mn | 671.70 Mn | - | - |
| 6 | Edap Tms | 154.62 Mn | 133.07 Mn | 7.34 Mn | 212.81% |
| 7 | Accendra Health | 90.69 Mn | 83.04 Mn | 263.41 Mn | -2,108.47% |
| 8 | 111 | 31.31 Mn | -27.44 Mn | 18.18 Mn | -601.44% |
| 9 | Cosmos Health | 13.28 Mn | 10.84 Mn | 1.51 Mn | -60.30% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | 13.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 136.24% |
| Mar 31, 2026 | -78.03% |
| Dec 31, 2025 | 12.94% |
| Sep 30, 2025 | 567.44% |
| Jun 30, 2025 | -45.25% |
| Mar 31, 2025 | 79.44% |
| Dec 31, 2024 | -122.81% |
| Sep 30, 2024 | 295.45% |
| Jun 30, 2024 | -11.35% |
| Mar 31, 2024 | 37.60% |
| Dec 31, 2023 | -220.47% |
| Sep 30, 2023 | -117.97% |
| Jun 30, 2023 | 1.87% |
| Mar 31, 2023 | 74.93% |
| Dec 31, 2022 | -120.75% |
| Sep 30, 2022 | 6,900.00% |
| Jun 30, 2022 | 46.20% |
| Mar 31, 2022 | -59.18% |
| Dec 31, 2021 | 62.85% |
| Sep 30, 2021 | -102.19% |